Company profile: LexaGene
1.1 - Company Overview
Company description
- Provider of molecular diagnostic systems for detecting pathogens and other molecular markers.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LexaGene
Calviri
HQ: United States
Website
- Description: Provider of cancer vaccines and diagnostics combining the immunogenic source of neoantigens with a peptide array platform, including a preventative vaccine targeting cancer-causing agents, a diagnostic blood test detecting immune responses to tumor-specific neoantigens, and a therapeutic vaccine stimulating the immune system to attack existing cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calviri company profile →
Culture Biosciences
HQ: United States
Website
- Description: Provider of cloud-connected bioreactors and Console software enabling remote, real-time design, monitoring, and analysis of cell culture and bioprocess experiments, plus bioprocess development services including clone screening, process characterization, media screening, and process optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Culture Biosciences company profile →
Immunologix
HQ: United States
Website
- Description: Provider of antibody-based therapeutics, producing human monoclonal antibodies targeting viral, bacterial, and tumor antigens, as well as human auto antigens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunologix company profile →
Nanoplex Technologies
HQ: United States
Website
- Description: Provider of nanoparticle-based products for life science research, enabling ultra-sensitive molecular identification and quantitation, as well as authentication and tracking applications; focused on rapidly translating state-of-the-art nanoscience into practical, valuable products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nanoplex Technologies company profile →
DiaSys Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic system solutions, offering over 90 liquid-stable, ready-to-use reagents for clinical chemistry and immunoturbidimetric diagnostics (routine and special), including Procalcitonin FS, LDH 21 FS, LDL-c direct FS, and Total bile acids 21 FS, as well as automated and semi-automated clinical chemistry analyzers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DiaSys Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LexaGene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LexaGene
2.2 - Growth funds investing in similar companies to LexaGene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LexaGene
4.2 - Public trading comparable groups for LexaGene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →